Search for: "Endo Pharmaceutical"
Results 181 - 200
of 254
Sorted by Relevance
|
Sort by Date
25 Oct 2008, 12:03 am
Sandoz, Inc (Law360) (Hal Wegner) (Patently-O) (Patent Prospector) (PLI) Cipro (Ciprofloxacin) - US: CAFC finds no antitrust liability for Hatch-Waxman reverse payment settlements: In Re Ciproflaxacin Hydrochloride Antitrust Litigation (IP Law Observer) Lescol (Fluvastatin) - US: Mylan confirms first-to-file patent challenge to Lescol by Novartis (SmartBrief) Levaquin (Levofloxacin) - UK: Levofloxacin SPC valid: Generics (UK) Ltd v Daiichi Pharmaceutical Co Ltd & Anor (IPKat)… [read post]
22 Aug 2013, 4:22 am
Senate Finance Committee sent letters to Purdue, Endo Pharmaceuticals and Johnson & Johnson requesting information about the companies’ ties to medical groups and physicians, saying it was exploring the possibility that organizations such as the American Pain Foundation, American Academy of Pain Medicine and American Pain Society, have “promoted misleading information about the risks and benefits of opioids while receiving financial support from opioid… [read post]
28 Feb 2014, 1:36 pm
Even more so I can only imagine now that drug manufacture, Endo Pharmaceuticals is ready to release a new long-acting testosterone injection known as Aveed. [read post]
18 Mar 2010, 2:30 am
(Patent Docs) Opana (Oxymorphone) - US: District Court New Jersey: Patent infringement complaint following a Paragraph IV Certification: Endo Pharmaceuticals Inc. et al. v. [read post]
15 Sep 2011, 11:35 am
He is a distinguished professional who built Endo Laboratories into one of the nation’s largest privately held pharmaceutical companies. [read post]
24 Aug 2011, 12:33 am
USPTO (Patent Docs) US: ALJ Rogers sets procedural schedule in Certain Coenzyme Q10 (337-TA-790) (ITC 337 Law Blog) Products Actos (Pioglitazone) – Brazil: STJ rules against extension of patent related to Actos (IP tango) Frova (Frovatriptan) – US: Endo Pharmaceuticals files patent infringement complaint against Mylan in response to Para IV certification filing (Patent Docs) Gemzar (Gemcitabine) – US: ALJ Rogers grants motion to terminate investigation in… [read post]
20 Mar 2023, 5:06 pm
For example, as discussed here, in January 2021, a plaintiff shareholder filed an opioid-related securities suit against Wal-Mart, pertaining to the retail giant’s pharmaceutical operations. [read post]
19 Oct 2010, 10:42 pm
General WTO paragraph 6 meeting aims at improved use of health waiver (IP Watch) The absence of investment in new antibiotics (IPBiz) Integration of intellectual property and regulatory exclusivity strategies for life science companies (IP Spotlight) Pharmaceutical companies can innovate if they want to (profitability through simplicity) Medicines Patent Pool seeks business director (IP Watch) WHO moves IP, innovation out of Director General’s office (IP Watch) A rights-poor… [read post]
4 Jan 2017, 8:26 am
The other shoe dropped when earlier this month the DOJ announced charges against two executives from Heritage Pharmaceuticals for fixing prices of antibiotics and diabetes treatments. [read post]
8 Aug 2012, 8:03 am
Companies involved include Bard, Boston Scientific Group, American Medical Systems and Endo Pharmaceutical Holdings, Inc. [read post]
4 Jan 2017, 8:26 am
The other shoe dropped when earlier this month the DOJ announced charges against two executives from Heritage Pharmaceuticals for fixing prices of antibiotics and diabetes treatments. [read post]
8 Sep 2011, 9:51 pm
Manufacturers including J&J and Endo Pharmaceuticals Holdings Inc. [read post]
6 Jul 2011, 2:21 am
(2) (PatLit) Lidoderm (Lidocaine) – US: Delaware District Court decision in Endo Pharmaceuticals patent case favors Watson (GenericsWeb) Lidoderm (Lidocaine) – US: Endo files patent infringement suit against Watson in response to Para IV challenge (Patent Docs) Lipitor (Atorvastatin) – UK: English Patent Court grants temporary restraining order against Teva on short notice – Pfizer threatens pharmacies with legal action over generic Atorvastatin… [read post]
16 Jun 2010, 3:02 pm
Zydus Pharmaceuticals USA, Inc. et al. [read post]
3 Mar 2010, 5:05 am
(IP Osgoode) Australia: University of Western Australia’s application to appeal FCAFC’s decision in University of Western Australia v Gray fails (IP Whiteboard) Colombia/EU/Peru: Tough IP health provisions in Europe’s Colombia/Peru trade deal (IP Watch) (IP tango) EU: Something more about Swiss type claims: G02/08 (SiNApSE) (SiNApSE) US: Pharmaceutical patent settlements – and what about patients? [read post]
3 Mar 2010, 5:05 am
(IP Osgoode) Australia: University of Western Australia’s application to appeal FCAFC’s decision in University of Western Australia v Gray fails (IP Whiteboard) Colombia/EU/Peru: Tough IP health provisions in Europe’s Colombia/Peru trade deal (IP Watch) (IP tango) EU: Something more about Swiss type claims: G02/08 (SiNApSE) (SiNApSE) US: Pharmaceutical patent settlements – and what about patients? [read post]
27 Feb 2009, 5:00 am
USA, Inc (Orange Book Blog) (FDA Law Blog) (Patent Baristas) (Law360) (Patent Docs) (Patent Prospector) (Patently-O) (GenericsWeb) (Hal Wegner) Famvir (Famciclovir) – US: Teva loses bid to toss Novartis wilful infringement claims over Famvir (Law360) Fentora (Fentanyl) – US: Barr alleges Cima and Cephalon’s patent suit just a delay tactic (Law360) Integrilin (Eptifibatide) – US: Schering alleges patent infringement following Teva’s Para IV… [read post]
15 Jul 2009, 5:15 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: European Commission Competition DG releases final report on pharmaceutical sector (IPKat) (PatLit) (BLOG@IP::JUR) (IAM) (Managing Intellectual Property) (Intellectual Property Watch) (The SPC Blog) (IAM) US: Follow-on biologics proposals considered by US Senate HELP Committee; Committee passes amendment for 12-year biologics exclusivity period… [read post]
23 Jan 2019, 9:30 pm
In a rare instance of such a withdrawal decision, FDA recently requested the removal of Opana ER—a painkilling opioid manufactured and marketed by Endo Pharmaceuticals—from the pharmaceutical market. [read post]
25 Apr 2011, 3:24 am
(PFE), Johnson & Johnson (JNJ) and Endo Pharmaceuticals Holdings Inc. [read post]
